BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 20, 2015
View Archived Issues
Researchers identify highly potent dengue-neutralizing MAb
Read More
ID Pharma enters new agreement with National Institute of Infectious Diseases of Japan
Read More
Atlas Genetics enters into diagnostic collaboration based on io system
Read More
Grant supports InMed's development of nanoparticle-based delivery system for glaucoma
Read More
Sanofi and Innate Pharma to collaborate on antibody-drug conjugates for cancer
Read More
SELLAS unites with TrojanTec on TR-1 cancer technology
Read More
Cystic Fibrosis Foundation Therapeutics and Genzyme expand collaboration
Read More
NeuroVive partners with Isomerase Therapeutics on NVP-014 for stroke
Read More
AnaptysBio initiates IND-enabling studies of anti-IL-36R MAb ANB-019
Read More
Novel mutation in the PEX3 gene may cause lethal ZSS
Read More
New company Oncurious to develop TB-403 for brain tumors
Read More
HIF-2alpha antagonist PT-2385 for clear cell renal carcinoma
Read More
ProMetic to raise USD 50 million in share deal
Read More
HER2-targeting ADC shows promise as a stable targeted therapeutic for multiple cancers
Read More
Cepheid's point-of-care HCV and HIV tests receive European approval
Read More
Novel immunotherapy combination improves outcome in no-sq NSCLC patients
Read More
Shenzhen Qianhai Taxus invests in Angionetics
Read More
WHO grants INNs for two Hanmi drugs
Read More
Phase III study of Opdivo in NSCLC stopped early after meeting primary endpoint
Read More
FDA awards orphan drug status to Samcyprone for malignant melanoma stage IIB to IV
Read More
Reolysin receives FDA orphan drug designation for malignant glioma
Read More
Ventria Bioscience develops fusion protein as vaccine for Lyme disease
Read More
U.S. HHS patent covers anti-JC virus ASOs
Read More
Jiva Pharma reports metformin salts
Read More
Peking University reports 14-3-3E inhibitors
Read More